Benadiba Joy, Michel Gérard, Auquier Pascal, Chastagner Pascal, Kanold Justyna, Poirée Marilyne, Plantaz Dominique, Padovani Laetitia, Berbis Julie, Barlogis Vincent, Contet Audrey, Chambost Hervé, Sirvent Nicolas
Departments of *Pediatric Hematology-Oncology #Radiotherapy, APHM, La Timone Hospital, Marseille, Bouches du Rhône †Department of Public Health, EA 3279 Research Unit, University Hospital Marseille, Aix-Marseille University, Marseille ‡Department of Pediatric Hematology-Oncology, University Hospital of Nancy, Nancy, Meurthe-et-Moselle §Department of Pediatric Hematology-Oncology, CIC Inserm 501, University Hospital of Clermont-Ferrand, Clermont-Ferrand, Auvergne ∥Department of Pediatric Hematology-Oncology, University Hospital of Nice, Nice, Alpes Maritimes ¶Department of Pediatric Hematology-Oncology, University Hospital of Grenoble, Grenoble, Isère **Department of Pediatric Hematology-Oncology, University Hospital of Montpellier, Languedoc-Roussillon, France.
J Pediatr Hematol Oncol. 2015 Mar;37(2):109-16. doi: 10.1097/MPH.0000000000000209.
We evaluated the impact of central nervous system irradiation (CNSI) on long-term health status and quality of life (QoL) of childhood lymphoblastic leukemia survivors included in the French L.E.A. (Childhood and Adolescent Leukemia) multicentric cohort. QoL was self-reported in adults and assessed by parents in children and adolescents, using adapted questionnaires. From 2004 to 2009, 630 nongrafted patients were assessed after 11.8±6.3 years from diagnosis. Patients receiving CNSI (18.6%) or chemotherapy alone (81.4%) were compared. The risk of having long-term physical effects was increased with CNSI (odds ratio=3.3; 95% confidence interval, 1.8-5.9), especially regarding growth failure, second tumor, cataract, and overweight. QoL did not differ significantly according to the treatment received, despite a tendency toward lower scores with CNSI in children and adolescents (summary score 63.6±13.3 vs. 71.7±12.4, P=0.14). Compared with French norms, adult survivors had an impaired QoL, especially in mental domains (mental composite score 45.2±9.8 vs. 47.9±2.1, P<0.001). In pediatric survivors, QoL was not impaired and even tended to be higher than population norms (summary score 71.7±12.4 vs. 70.0±4.2, P=0.054), mainly in social and relational domains. In conclusion, QoL seems to be impaired by the trauma of a life-threatening illness in childhood, as well as by the treatment received.
我们评估了中枢神经系统照射(CNSI)对法国L.E.A.(儿童和青少年白血病)多中心队列中儿童淋巴细胞白血病幸存者长期健康状况和生活质量(QoL)的影响。生活质量由成年人自我报告,儿童和青少年则由父母使用经过改编的问卷进行评估。2004年至2009年,对630例未接受移植的患者在诊断后11.8±6.3年进行了评估。比较了接受中枢神经系统照射(18.6%)或单纯化疗(81.4%)的患者。中枢神经系统照射会增加出现长期身体影响的风险(优势比=3.3;95%置信区间,1.8 - 5.9),尤其是在生长发育迟缓、二次肿瘤、白内障和超重方面。无论接受何种治疗,生活质量均无显著差异,尽管儿童和青少年接受中枢神经系统照射时得分有降低趋势(综合得分63.6±13.3 vs. 71.7±12.4,P = 0.14)。与法国标准相比,成年幸存者的生活质量受损,尤其是在心理领域(心理综合得分45.2±9.8 vs. 47.9±2.1,P<0.001)。在儿科幸存者中,生活质量未受损,甚至有高于人群标准的趋势(综合得分71.7±12.4 vs. 70.0±4.2,P = 0.054),主要体现在社会和人际关系领域。总之,生活质量似乎受到童年危及生命疾病的创伤以及所接受治疗的影响。